Susumu Okano

845 total citations
63 papers, 492 citations indexed

About

Susumu Okano is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Susumu Okano has authored 63 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 35 papers in Otorhinolaryngology and 27 papers in Surgery. Recurrent topics in Susumu Okano's work include Head and Neck Cancer Studies (34 papers), Lung Cancer Treatments and Mutations (13 papers) and Head and Neck Surgical Oncology (13 papers). Susumu Okano is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Lung Cancer Treatments and Mutations (13 papers) and Head and Neck Surgical Oncology (13 papers). Susumu Okano collaborates with scholars based in Japan, United States and Germany. Susumu Okano's co-authors include Makoto Tahara, Tomohiro Enokida, Takao Fujisawa, Ryuichi Hayashi, Sadamoto Zenda, Naomi Kiyota, Tetsuo Akimoto, Atsushi Motegi, Takeshi Kodaira and Yusuke Onozawa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Susumu Okano

47 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susumu Okano Japan 12 217 216 201 190 71 63 492
Pingzhang Tang China 14 336 1.5× 164 0.8× 157 0.8× 342 1.8× 104 1.5× 112 751
Anja A. Dünne Germany 12 265 1.2× 263 1.2× 64 0.3× 217 1.1× 109 1.5× 16 514
Remco de Bree Netherlands 8 214 1.0× 289 1.3× 99 0.5× 187 1.0× 126 1.8× 14 563
Nikolaus Möckelmann Germany 13 148 0.7× 178 0.8× 86 0.4× 196 1.0× 81 1.1× 32 396
Enrico Dessy Italy 13 119 0.5× 90 0.4× 138 0.7× 98 0.5× 105 1.5× 24 431
Choichi Horiuchi Japan 17 224 1.0× 328 1.5× 186 0.9× 275 1.4× 69 1.0× 40 596
Alfonso Berrocal Spain 12 138 0.6× 44 0.2× 102 0.5× 92 0.5× 74 1.0× 30 381
Siyi Li China 12 167 0.8× 120 0.6× 42 0.2× 177 0.9× 127 1.8× 32 433
Tai‐Jan Chiu Taiwan 13 196 0.9× 101 0.5× 97 0.5× 107 0.6× 161 2.3× 56 431

Countries citing papers authored by Susumu Okano

Since Specialization
Citations

This map shows the geographic impact of Susumu Okano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Okano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Okano more than expected).

Fields of papers citing papers by Susumu Okano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Okano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Okano. The network helps show where Susumu Okano may publish in the future.

Co-authorship network of co-authors of Susumu Okano

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Okano. A scholar is included among the top collaborators of Susumu Okano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Okano. Susumu Okano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Enokida, Tomohiro, Susumu Okano, Takao Fujisawa, et al.. (2024). Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer. International Journal of Clinical Oncology. 29(10). 1435–1443.
3.
Tajiri, Kazuko, Shinya Suzuki, Tomohiro Enokida, et al.. (2023). Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer. Cancer Medicine. 12(22). 20773–20782. 4 indexed citations
4.
Enokida, Tomohiro, Susumu Okano, Masanobu Sato, et al.. (2023). Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer. 184. 30–38. 6 indexed citations
5.
Okano, Susumu, Makoto Tahara, Yoshinori Imamura, et al.. (2023). Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy.. Journal of Clinical Oncology. 41(16_suppl). 6093–6093. 2 indexed citations
6.
Suzuki, Shinya, Atsunobu Sagara, Tomohiro Enokida, et al.. (2023). Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer. Frontiers in Oncology. 13. 1154771–1154771. 5 indexed citations
7.
8.
Enokida, Tomohiro, Shinya Suzuki, Takao Fujisawa, et al.. (2023). A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer. Frontiers in Oncology. 13. 1145323–1145323.
9.
Enokida, Tomohiro, Susumu Okano, Takao Fujisawa, et al.. (2023). 2228P Long-term clinical outcomes of Lenvatinib in patients with differentiated thyroid cancer: Results from the real-world practice of a single institution. Annals of Oncology. 34. S1147–S1147. 2 indexed citations
10.
Tanaka, Hideki, Tomohiro Enokida, Susumu Okano, et al.. (2023). Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck. Frontiers in Oncology. 13. 1221352–1221352. 4 indexed citations
11.
Imamura, Yoshinori, Naomi Kiyota, Makoto Tahara, et al.. (2022). Systemic therapy for salivary gland malignancy: current status and future perspectives. Japanese Journal of Clinical Oncology. 52(4). 293–302. 22 indexed citations
12.
Saito, Yuki, Akihiro Homma, Naomi Kiyota, et al.. (2022). Human papillomavirus-related oropharyngeal carcinoma. Japanese Journal of Clinical Oncology. 52(7). 700–706. 2 indexed citations
13.
14.
Monden, Nobuya, Takahiro Asakage, Naomi Kiyota, et al.. (2019). A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition). Japanese Journal of Clinical Oncology. 49(7). 589–595. 25 indexed citations
15.
Tahara, Makoto, et al.. (2018). Clinical Effect of Dose Escalation of Lenvatinib After Disease Progression in Patients With Metastatic Thyroid Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1384–1385. 1 indexed citations
16.
Tahara, Makoto, et al.. (2018). Platinum-Based Chemotherapy Plus Cetuximab in Patients With Recurrent or Metastatic Nasopharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1371–1371.
17.
Hama, Takanori, et al.. (2012). A clinicopathological study of hypopharynx-larynx partial resection for hypopharyngeal squamous-cell carcinoma. Toukeibu Gan. 38(4). 420–424. 1 indexed citations
18.
Kato, Takakuni, et al.. (2006). A STUDY OF HYPOPHARYNGEAL CANCER DIADNOSED USING A NARROW BAND IMAGING ENDOSCOPE. Toukeibu Gan. 32(1). 56–60. 1 indexed citations
19.
Takahashi, Haruo, Susumu Okano, & Masakatsu Ichinoe. (2001). Present situation for production of pistachio nuts in Iran.. JSM Mycotoxins. 51(2). 95–102. 3 indexed citations
20.
Okano, Susumu, et al.. (1987). [Two cases of unresectable pancreatic cancer responding to combined chemotherapy with cisplatin, PSK and UFT].. PubMed. 14(6 Pt 1). 1926–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingzhang Tang Breakdown of academic impact, for papers by Anja A. Dünne Breakdown of academic impact, for papers by Remco de Bree Breakdown of academic impact, for papers by Nikolaus Möckelmann Breakdown of academic impact, for papers by Enrico Dessy Breakdown of academic impact, for papers by Choichi Horiuchi Breakdown of academic impact, for papers by Alfonso Berrocal Breakdown of academic impact, for papers by Siyi Li Breakdown of academic impact, for papers by Tai‐Jan Chiu
Rankless by CCL
2026